Randy Burd, Ph.D. is the Director of Research at BerylStone and an Associate Professor at University of Arizona. Randy received his Ph.D. in Molecular and Cellular Biophysics in 1998 from the Roswell Park Cancer Institute in Buffalo, New York and has worked in the area of pharmaceutical and biotechnology research for over a decade. In 2002 he was appointed the director of Pre-Clinical Therapeutics at Thomas Jefferson University. In 2005 he was recruited to the University of Arizona. Randy joined BerylStone in 2011 and currently co-manages BerylStone Investment's Managed Portfolios. Twitter- @randymburd Linkedin- http://www.linkedin.com/in/rburd
Scott is the Principal and CIO of BerylStone Investments, and independent advisory firm. Scott received his Chartered Financial Analyst (CFA) designation in 2001 and his Bachelors of Science with honors from the University of Colorado Leeds School of Business in 1992.
Individual investor. I have been trying to create wealth for me and my family for over 30 years. The market correction since the early 80's have paired gains, plus some bad choices.
Still looking for something that works.
I hold BS degrees in Biology and Environmental Policy in addition to an M.Ed in Science Education. I have experience as a researcher in the biotech sector. Currently, I teach Biology courses as well as publish articles and research in the fields of science, education and public policy.